Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03508635Phase 1Completed
CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
Healthy
PrincipalinvestigatorStart date: 2014-09-01
NCT02231671Phase 1Completed
A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176
Respiratory Syncytial Virus Infections
PrincipalinvestigatorStart date: 2014-08-31
NCT02293967Phase 1Completed
Mass Balance Study of MT-1303
Relapsing-remitting Multiple Sclerosis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03508635Phase 1PrincipalInvestigator

CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

Healthy
Completed
NCT02231671Phase 1PrincipalInvestigator

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Respiratory Syncytial Virus Infections
Completed
NCT02293967Phase 1PrincipalInvestigator

Mass Balance Study of MT-1303

Relapsing-remitting Multiple Sclerosis
Completed

All 3 trials loaded